Single-Center Study of 103 Consecutive Parkinson's Disease Patients with Levodopa-Carbidopa Intestinal Gel

Tutkimustuotos: ArtikkelijulkaisuArtikkeliTieteellinenvertaisarvioitu

Alkuperäiskielienglanti
LehtiMovement disorders clinical practice
Vuosikerta9
Numero1
Sivut60-68
Sivumäärä9
ISSN2330-1619
DOI - pysyväislinkit
TilaJulkaistu - tammik. 2022
OKM-julkaisutyyppiA1 Alkuperäisartikkeli tieteellisessä aikakauslehdessä, vertaisarvioitu

Lisätietoja

Funding Information:
: V.V. has received a grant from the Finnish Parkinson Foundation and Helsinki University Hospital. M.T. has received a grant from the Finnish Parkinson Foundation, Emil Aaltonen's Foundation, and the Finnish‐Norwegian Medical Foundation. Funding Sources and Conflicts of Interest

Funding Information:
: V.V. has no additional disclosures to report. M.T. has no additional disclosures to report. P.K.A.M. has received lecture fees from AbbVie and a personal grant from Helsinki University. K.M. has no disclosures to report. E.R.J. has no disclosures to report. U.M. has received lecture fees from AbbVie. P.E. is a member of the MDS Non‐Motor Parkinson's Disease Study Group and consulting neurologist for Finnish Patient Insurance Centre. He has received consulting fees from NordicInfu Care AB and AbbVie. He is a member of Advisory board in AbbVie. He has received lecture fees from Abbott, AbbVie, and NordicInfu Care; and is currently a PI in Finland of International Adroit‐study (Abbott DBS Registry of Outcomes for Indications over Time). 2021‐: Organized by Abbott. Financial Disclosures for the Previous 12 Months

Publisher Copyright:
© 2021 International Parkinson and Movement Disorder Society

Tieteenalat

  • 3112 Neurotieteet

Siteeraa tätä